Impact of Sex on Clinical Outcomes in Patients undergoing Complex Percutaneous Coronary Angioplasty (from the e-ULTIMASTER Study).


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 01 2023
Historique:
received: 11 08 2022
revised: 03 10 2022
accepted: 13 10 2022
pubmed: 12 11 2022
medline: 7 12 2022
entrez: 11 11 2022
Statut: ppublish

Résumé

Female gender has been shown to be associated with worse clinical outcomes after percutaneous coronary intervention (PCI). However, the impact of gender on the clinical outcomes of complex PCI is still poorly understood. This study examined the differences in patient and coronary lesion characteristics and longer-term clinical outcomes in male and female patients who underwent complex PCI. This was a sub-analysis of the e-ULTIMASTER study, which was a large, multicontinental, prospective, observational study enrolling 37,198 patients who underwent PCI with the Ultimaster stent. Patients who underwent complex PCI were stratified by gender. The primary outcome was target lesion failure at 12 months, defined as the composite of cardiac death, target vessel-related myocardial infarction, and clinically driven target lesion revascularization at 12 months. A total of 13,623 patients underwent complex procedures, of which 35.7% were women. Women were twice as likely as men to be aged ≥80 years (17.6% vs 9%, p <0.0001) and had a higher prevalence of cardiovascular risk factors. Women had fewer lesions treated than men (1.5 ± 0.8 vs 1.6 ± 0.8, p <0.0001) and fewer stents implanted (2.0 ± 1.1 vs 2.1 ± 1.1, p <0.0001). There was no statistically significant difference in clinical outcomes at 12 months between women and men. Event rates were comparable in women and men for target lesion failure (4.7% vs 4.3%, p = 0.30), target vessel failure (5.1% vs 4.9%, p = 0.73), and cardiac death (1.8% vs 1.7%, p = 0.80).In conclusion, our findings suggest no significant differences in clinical outcomes between women and men who underwent complex PCI.

Identifiants

pubmed: 36368145
pii: S0002-9149(22)01118-3
doi: 10.1016/j.amjcard.2022.10.023
pii:
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

71-79

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Gemina Doolub (G)

Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele, Newcastle, United Kingdom; Bristol Heart Institute, Bristol, United Kingdom. Electronic address: gemina@doctors.org.uk.

Pim A L Tonino (PAL)

Catharina Hospital, Eindhoven, The Netherlands.

Sasko Kedev (S)

St. Cyril & Methodius University, Vodnjanska, Skopje, Macedonia.

Jacques Monségu (J)

Cardiovascular Institute, Groupe Hospitalier Mutualiste, Grenoble, France.

Valeria Paradies (V)

Department of Cardiology, Maasstad Hospital, Rotterdam, The Netherlands.

David Austin (D)

Academic Cardiovascular Unit, The James Cook University Hospital, Middlesbrough, United Kingdom.

Fabrizio Spanó (F)

Department of Cardiology, Meander Medical Center, Amersfoort, The Netherlands.

Marco Roffi (M)

Division of Cardiology, University Hospitals Geneva, Geneva, Switzerland.

Ole Fröbert (O)

Faculty of Health, Örebro University, Örebro, Sweden.

Clemens von Birgelen (C)

Thorax Centrum Twente, Medisch Spectrum Twente, Enschede, The Netherlands.

Louise Buchanan (L)

Cardiology Department, North Cumbria Integrated Care National Health Service Foundation Trust, Carlisle, United Kingdom.

Mamas A Mamas (MA)

Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele, Newcastle, United Kingdom. Electronic address: mamasmamas1@yahoo.co.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH